Related Experiment Video

Updated: Mar 17, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.6K

The mystery of oncogenic KRAS: Lessons from studying its wild-type counter part

Yuan-I Chang1,2, Alisa Damnernsawad1,3, Guangyao Kong1

  • 1a McArdle Laboratory for Cancer Research, University of Wisconsin-Madison , Madison , WI , USA.

Small Gtpases
|July 25, 2016
PubMed

Insights

Oncogenic Kras is more potent in causing leukemia than Nras due to unique signaling properties. This study explores Kras function in hematopoiesis and leukemogenesis, identifying key mechanisms.

Area of Science:

  • Molecular biology
  • Cancer research
  • Hematopoiesis

Background:

  • Ras proteins (Kras and Nras) share high sequence identity.
  • Oncogenic Kras exhibits significantly greater leukemogenic activity than oncogenic Nras in vivo.
  • Understanding the differential functions of Kras and Nras in leukemogenesis is crucial.

Purpose of the Study:

  • To characterize wild-type Kras function in adult hematopoiesis.
  • To investigate the mechanisms underlying oncogenic Kras-induced leukemogenesis.
  • To identify unique aspects of Kras signaling contributing to its potent leukemogenic activity.

Main Methods:

  • Conditional knock-in mouse models.
  • Analysis of adult hematopoiesis.
  • Characterization of Ras signaling pathways in vivo.

Main Results:

  • Kras, but not Nras, is essential for mediating specific ERK1/2 signaling in certain cell types and cytokines.
  • Oncogenic Kras uniquely hyperactivates wild-type Ras, amplifying Ras signaling.
  • These findings highlight distinct mechanisms driving Kras-mediated leukemogenesis.

Conclusions:

  • The potent leukemogenic activity of oncogenic Kras stems from its unique role in ERK1/2 signaling and its ability to hyperactivate wild-type Ras.
  • Further research into these mechanisms may reveal novel therapeutic strategies for Kras-driven leukemias.
  • Targeting oncogenic Kras signaling offers a potential therapeutic avenue.
Keywords:
SOS1leukemogenesisoncogenic Krasoncogenic Nraswild-type Kras

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

18.8K
Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells09:20

Reliably Engineering and Controlling Stable Optogenetic Gene Circuits in Mammalian Cells

Published on: July 6, 2021

2.9K

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.5K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
11.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

5.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
5.6K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
10.0K